Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antagonists marijuana

Compton WM, Grant BF, Colliver JD, et al Prevalence of marijuana use disorders in the United States 1991-1992 and2001-2002. JAMA291 2114-2121,2004 Cook SA, Lowe JA, Martin BR CBl receptor antagonist precipitates withdrawal in mice exposed to delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 285 1150— 1156, 1998... [Pg.177]

Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134 943-944 Huestis MA, GoreUck DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA (2001) Blockade of effects of smoked marijuana by the CB 1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 58 322-328... [Pg.361]

Zickler, P. (2002). Cannabinoid Antagonist Reduces Marijuana s Effects in Humans. NIDA Notes 17 (3). http //www.drugabuse.gov/NIDA notes/NNVol17N3/ Cannabinoid.html)... [Pg.10]

Huestis, M.A. (2001, April) Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716. Jouma/ Archives of General Psychiatry 58 (4) 322-328. http //archpsyc.ama-assn.org/cgi/conieni/absiract/58/4/322 (for abstract)... [Pg.44]

FIGURE 13-16. Icon for marijuana antagonist, theoretically a treatment for drug abuse and for use in testing for schizophrenia. [Pg.518]

Cannabinol Cannabis saliva (marijuana) AND-R antagonist [0.6] [anti-... [Pg.455]

The appetite-stimulating effects of marijuana have been known for centuries and constitute one of the established medicinal uses of cannabis preparations. Today THC (dronabinol/Marinol) is clinically used for the treatment of cachexia-anorexia in human immunodeficiency virus (HIV) and palliative care patients. There have also been very promising advances in the development of a cannabinoid receptor antagonist (SR141716A, now named Rimonabant or Acomplia) for the treatment of obesity. [Pg.134]

Marijuana intoxication precipitates psychosis, paranoid thoughts, anxiety, and restlessness NE-augmenting agents (0 2-adrenergic antagonists, yB-agonists, NE reuptake inhibitors)... [Pg.1259]

Cannabinoid research and the use of caimabis products continue to attract significant attention. The current dramatic advances in molecular biology and technology that increased scientific knowledge in cannabinoid research will certainly contribute to a better policy on the medical use of marijuana. For example, preliminary studies with CBR antagonists have contributed to resolving... [Pg.59]

See other pages where Antagonists marijuana is mentioned: [Pg.175]    [Pg.178]    [Pg.528]    [Pg.120]    [Pg.136]    [Pg.138]    [Pg.6]    [Pg.919]    [Pg.323]    [Pg.496]    [Pg.45]    [Pg.517]    [Pg.30]    [Pg.476]    [Pg.813]    [Pg.230]    [Pg.455]    [Pg.13]    [Pg.446]    [Pg.587]    [Pg.707]    [Pg.210]    [Pg.943]    [Pg.61]    [Pg.69]    [Pg.70]    [Pg.74]    [Pg.83]    [Pg.89]    [Pg.92]    [Pg.93]    [Pg.102]    [Pg.103]    [Pg.119]    [Pg.237]    [Pg.240]   
See also in sourсe #XX -- [ Pg.517 , Pg.518 , Pg.518 ]



SEARCH



Marijuana

© 2024 chempedia.info